Physician profile
Anna M Mclemore
NPI 1831453034
$1,238.37
in general payments reported to CMS, 2019-2025
14 companies · $75.89 in 2025
The $75.89 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $95.87 · 2020: $73.13 · 2021: $11.08 · 2022: $37.51 · 2023: $765 · 2024: $180 · 2025: $75.89.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517 · Travel and Lodging: $504.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $517.27 |
| Travel and Lodging | $503.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $592.95 | 2023 | Na |
| Medtronic, INC. | $151.23 | 2022-2024 | Closurefast |
| Depuy Synthes Sales INC. | $148.97 | 2023 | Crosstie, Na |
| Smith+Nephew, INC. | $87.83 | 2019-2025 | Grafix Pl |
| Averitas Pharma INC. | $72.98 | 2023-2025 | Qutenza |
| Osteomed LLC | $49.26 | 2019-2020 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $31.53 | 2020-2022 | |
| Solventum Corporation | $22.27 | 2024 | Activ.A.C. |
| Zimmer Biomet Holdings, INC. | $17.66 | 2020 | |
| Integra Lifesciences Corporation | $14.42 | 2019 | |
| Arthrosurface Incorporated | $13.29 | 2019 | |
| Horizon Therapeutics Plc | $13.26 | 2019 | |
| Merck Sharp & Dohme LLC | $11.64 | 2019 | |
| Melinta Therapeutics, LLC | $11.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anna Mclemore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.